- For Patients
- Introduction to the Marshall Protocol
-
Length of the MP - Immunopathology
- Managing Immunopathology
- Food and Drink
- Light Restriction
- Suitability of the Marshall Protocol
- Starting the Marshall Protocol
- Working with a Physician
- Phase One Guidelines
- Phase Two/Three Guidelines
- Palliative vs. Curative Treatments
- Patient Interviews on Bacteriality
- Non-MP Treatments
- Glossary
- For Physicians
- Publications and Presentations
- Science Behind Marshall Protocol
- Science Behind Immunopathology
- Science Behind Olmesartan (Benicar)
- Safety of Olmesartan (Benicar)
- Safety of MP Antibiotics
- Phase One Guidelines
- Phase Two/Three Guidelines
- Suitability of the Marshall Protocol
- Physicians' Concerns About the MP
- Notice for Emergency Medical Personnel
- For Researchers
- Publications and Presentations
- Science Behind Marshall Pathogenesis
- Science Behind Vitamin D
- Molecular Activity of Vitamin D and the VDR in Chronic Disease
- Th1 Spectrum Disorder – how chronic inflammatory diseases are related
- Transmission of Bacteria and Onset of Chronic Disease
- Successive Infection and Variability in Disease
- Evolutionary Perspective on Chronic Disease
- Incidence and Prevalence of Chronic Disease
- Evidence that Chronic Disease Is Caused by Pathogens
- About ARF
- Related Sites
Patient interviews
Dozens of different patients have shared their stories of recovery on Bacteriality.com.
chronic borreliosis (“Lyme”), multiple chemical sensitivities, chronic spinal inflammationThe complex biological response of vascular tissues to harmful stimuli such as pathogens or damaged cells. It is a protective attempt by the organism to remove the injurious stimuli as well as initiate the healing process for the tissue., peripheral neuropathy
Read the interview
sarcoidosis of the heart, coronary artery disease, atrial fibrillation
Read the interview
Lyme disease, irritable bowel syndrome/ulcerative colitis, radiculitis
Read the interview
Notes and comments
Julia wants her interview removed. -PA
